Literature DB >> 10691923

CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS.

H Choremi-Papadopoulou1, N Panagiotou, E Samouilidou, F Kontopidou, V Viglis, A Antoniadou, J Kosmidis, T Kordossis.   

Abstract

In a prospective study of 152 HIV-1 patients (with and without progression to AIDS) we examined CD28 MoAb costimulation and CD3 MoAb response using whole blood culture at baseline and up to either the time of AIDS diagnosis or the end of the observation period. CD28 antigen expression on both CD4+ and CD8+ T lymphocytes was also studied in both groups of patients. In patients who progressed to AIDS, CD28 MoAb costimulation was found to be decreased. Univariate time-dependent analysis showed that decreases in (i) absolute numbers of either CD4+, CD4+CD28+, CD8+CD28+ T cells, (ii) CD28 MoAb costimulation, and (iii) CD3 MoAb response, and an increase in CD8+CD28- %, are significant predictors for progression to AIDS. In addition, multivariate time-dependent analysis demonstrated that a decrease in CD28 MoAb costimulation (but not a decrease in CD3 MoAb response) was predictive for progression to AIDS, as were decreases in the percentage of CD4+ T cells and the absolute number of CD4+CD28+ T cells. Thus, CD28 MoAb costimulation can be considered a useful assay for monitoring HIV-1 infection. Furthermore, apart from the early increase in the percentage of CD8+CD28- T cells and an increase in the percentage of CD28- on CD8+ T cells in both groups of patients at baseline compared with normal controls, a negative correlation was found to exist between the percentages of CD4+ or CD4+CD28+ T cells and the percentage of CD8+CD28- T cells; this suggests that these cells are probably mutually regulated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691923      PMCID: PMC1905577          DOI: 10.1046/j.1365-2249.2000.01153.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells.

Authors:  M Labalette; F Salez; F R Pruvot; C Noel; J P Dessaint
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

2.  Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.

Authors:  N J Borthwick; M Bofill; W M Gombert; A N Akbar; E Medina; K Sagawa; M C Lipman; M A Johnson; G Janossy
Journal:  AIDS       Date:  1994-04       Impact factor: 4.177

3.  T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects.

Authors:  M T Roos; F Miedema; M Koot; M Tersmette; W P Schaasberg; R A Coutinho; P T Schellekens
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

Review 4.  New concepts in the immunopathogenesis of HIV infection.

Authors:  G Pantaleo; A S Fauci
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

5.  Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.

Authors:  M R Klein; I P Keet; J D'Amaro; R J Bende; A Hekman; B Mesman; M Koot; L P de Waal; R A Coutinho; F Miedema
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

6.  Expansion of a CD8+CD28- cell population in the blood and lung of HIV-positive patients.

Authors:  J J Saukkonen; H Kornfeld; J S Berman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-11

7.  Anergy and apoptosis in CD8+ T cells from HIV-infected persons.

Authors:  D E Lewis; D S Tang; A Adu-Oppong; W Schober; J R Rodgers
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

8.  Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

Authors:  J H Vingerhoets; G L Vanham; L L Kestens; G G Penne; R L Colebunders; M J Vandenbruaene; J Goeman; P L Gigase; M De Boer; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

9.  Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection.

Authors:  H Choremi-Papadopoulou; V Viglis; P Gargalianos; T Kordossis; A Iniotaki-Theodoraki; J Kosmidis
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-03

10.  Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.

Authors:  L Kestens; G Vanham; C Vereecken; M Vandenbruaene; G Vercauteren; R L Colebunders; P L Gigase
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

View more
  8 in total

1.  Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients.

Authors:  Wei Cao; Zhi-Feng Qiu; Tai-Sheng Li
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Early immune senescence in HIV disease.

Authors:  Seema Desai; Alan Landay
Journal:  Curr HIV/AIDS Rep       Date:  2010-02       Impact factor: 5.071

Review 3.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS.

Authors:  Byeong-Sun Choi; Yong-Keun Park; Joo-Shil Lee
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.

Authors:  Ronald D'Amico; Yijun Yang; Donna Mildvan; Scott R Evans; Carol T Schnizlein-Bick; Richard Hafner; Nancy Webb; Michael Basar; Robert Zackin; Mark A Jacobson
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

6.  Premature aging of T cells is associated with faster HIV-1 disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Rita B Effros; Roger Detels
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

7.  Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infection.

Authors:  Michael Schindler; Jan Schmökel; Anke Specht; Hui Li; Jan Münch; Mohammad Khalid; Donald L Sodora; Beatrice H Hahn; Guido Silvestri; Frank Kirchhoff
Journal:  PLoS Pathog       Date:  2008-07-18       Impact factor: 6.823

8.  Frailty, markers of immune activation and oxidative stress in HIV infected elderly.

Authors:  Susana Álvarez; Fátima Brañas; Matilde Sánchez-Conde; Santiago Moreno; Juan Carlos López-Bernaldo de Quirós; Mª Ángeles Muñoz-Fernández
Journal:  PLoS One       Date:  2020-03-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.